Published in J Virol on May 01, 1993
Hepatitis D virus RNA editing: specific modification of adenosine in the antigenomic RNA. J Virol (1995) 2.54
Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol (1993) 2.16
RNA-protein interactions: involvement of NS3, NS5, and 3' noncoding regions of Japanese encephalitis virus genomic RNA. J Virol (1997) 2.12
Sequence and structural elements at the 3' terminus of bovine viral diarrhea virus genomic RNA: functional role during RNA replication. J Virol (1999) 1.38
Specific interaction between the hepatitis C virus NS5B RNA polymerase and the 3' end of the viral RNA. J Virol (1999) 1.28
Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation. J Virol (1995) 1.27
Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent. J Virol (2005) 1.21
Genotype-specific complementation of hepatitis delta virus RNA replication by hepatitis delta antigen. J Virol (1998) 1.20
Mov34 protein from mouse brain interacts with the 3' noncoding region of Japanese encephalitis virus. J Virol (2000) 1.14
Self-association of a synthetic peptide from the N terminus of the hepatitis delta virus protein into an immunoreactive alpha-helical multimer. Proc Natl Acad Sci U S A (1995) 1.05
Mutational analysis of delta antigen: effect on assembly and replication of hepatitis delta virus. J Virol (1994) 1.01
Novel nuclear export signal-interacting protein, NESI, critical for the assembly of hepatitis delta virus. J Virol (2005) 0.98
Roles of the AX(4)GKS and arginine-rich motifs of hepatitis C virus RNA helicase in ATP- and viral RNA-binding activity. J Virol (2000) 0.97
Combined proteomic-RNAi screen for host factors involved in human hepatitis delta virus replication. RNA (2009) 0.95
Functional domains of delta antigens and viral RNA required for RNA packaging of hepatitis delta virus. J Virol (1995) 0.95
Hepatitis C virus NS5A protein down-regulates the expression of spindle gene Aspm through PKR-p38 signaling pathway. J Biol Chem (2008) 0.95
Differential inhibition of RNA editing in hepatitis delta virus genotype III by the short and long forms of hepatitis delta antigen. J Virol (2003) 0.90
Clathrin-mediated post-Golgi membrane trafficking in the morphogenesis of hepatitis delta virus. J Virol (2009) 0.84
Interaction and replication activation of genotype I and II hepatitis delta antigens. J Virol (2004) 0.83
Local helix content and RNA-binding activity of the N-terminal leucine-repeat region of hepatitis delta antigen. J Biomol NMR (1998) 0.81
Upregulation of the chemokine (C-C motif) ligand 2 via a severe acute respiratory syndrome coronavirus spike-ACE2 signaling pathway. J Virol (2010) 0.80
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science (1988) 27.01
Structure, sequence and expression of the hepatitis delta (delta) viral genome. Nature (1986) 7.38
Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen. J Virol (1989) 5.48
Structure and replication of the genome of the hepatitis delta virus. Proc Natl Acad Sci U S A (1986) 5.23
A replication cycle for viroids and other small infectious RNA's. Science (1984) 5.18
delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. Proc Natl Acad Sci U S A (1980) 5.12
Antigenomic RNA of human hepatitis delta virus can undergo self-cleavage. J Virol (1988) 4.59
Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA. Nature (1987) 4.52
A specific base transition occurs on replicating hepatitis delta virus RNA. J Virol (1990) 4.05
The hepatitis delta (delta) virus possesses a circular RNA. Nature (1986) 4.00
Purification and cloning of a mouse ribosomal gene fragment in coliphage lambda. Gene (1977) 3.79
Hepatitis delta virus: protein composition of delta antigen and its hepatitis B virus-derived envelope. J Virol (1986) 3.63
Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication. J Virol (1990) 3.57
Human hepatitis delta virus RNA subfragments contain an autocleavage activity. Proc Natl Acad Sci U S A (1989) 3.51
Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. J Virol (1988) 3.11
Antigens of hepatitis delta virus in the liver and serum of humans and animals. J Infect Dis (1986) 3.08
A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta. J Virol (1988) 2.99
Assembly of hepatitis delta virus particles. J Virol (1992) 2.36
Identification of a prenylation site in delta virus large antigen. Science (1992) 2.29
Characterization of hepatitis delta antigen: specific binding to hepatitis delta virus RNA. J Virol (1990) 2.17
Structural requirements for RNA editing in hepatitis delta virus: evidence for a uridine-to-cytidine editing mechanism. Proc Natl Acad Sci U S A (1992) 1.87
In vitro-synthesized hepatitis delta virus RNA initiates genome replication in cultured cells. J Virol (1990) 1.79
trans-dominant inhibition of human hepatitis delta virus genome replication. J Virol (1991) 1.79
Characterization of a dimerization motif in AP-2 and its function in heterologous DNA-binding proteins. Science (1991) 1.71
Small-form hepatitis B surface antigen is sufficient to help in the assembly of hepatitis delta virus-like particles. J Virol (1991) 1.67
Characterization of nuclear targeting signal of hepatitis delta antigen: nuclear transport as a protein complex. J Virol (1992) 1.63
Reversible cleavage and ligation of hepatitis delta virus RNA. Science (1989) 1.59
Sequence conservation and divergence of hepatitis delta virus RNA. Virology (1990) 1.56
A model for fibrinogen: domains and sequence. Science (1985) 1.53
Editing on the genomic RNA of human hepatitis delta virus. J Virol (1992) 1.48
A human monoclonal antibody that recognizes viral polypeptides and in vitro translation products of the genome of the hepatitis D virus. J Infect Dis (1987) 1.32
Immunogenic domains of hepatitis delta virus antigen: peptide mapping of epitopes recognized by human and woodchuck antibodies. J Virol (1990) 1.25
Functional study of hepatitis delta virus large antigen in packaging and replication inhibition: role of the amino-terminal leucine zipper. J Virol (1992) 1.25
Heterogeneity of hepatitis delta antigen. Virology (1990) 1.23
Nuclear localization signals, but not putative leucine zipper motifs, are essential for nuclear transport of hepatitis delta antigen. J Virol (1992) 1.07
Cloning and sequencing of RNA of hepatitis delta virus isolated from human serum. J Gen Virol (1990) 1.01
Cell culture model systems to study HDV expression, replication and pathogenesis. Prog Clin Biol Res (1991) 0.95
Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell (1986) 8.53
Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med (1997) 6.03
KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res (2001) 5.40
Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol (1989) 4.37
PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. Science (2000) 3.87
Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res (1985) 3.44
Risk of internal cancers from arsenic in drinking water. Environ Health Perspect (2000) 3.29
The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation. J Biol Chem (1987) 3.13
Prevalence of myopia in Taiwanese schoolchildren: 1983 to 2000. Ann Acad Med Singapore (2004) 3.01
KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. Am J Pathol (2000) 2.99
Arsenic and cancers. Lancet (1988) 2.93
Epidemiologic study of ocular refraction among schoolchildren in Taiwan in 1995. Optom Vis Sci (1999) 2.93
Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor beta pathway components. Proc Natl Acad Sci U S A (1996) 2.84
Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol (2001) 2.82
Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res (1995) 2.75
Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology (1997) 2.61
Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest (1997) 2.57
A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br J Cancer (1986) 2.37
Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis (1990) 2.30
Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med (2001) 2.26
Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst (2000) 2.23
Ingested inorganic arsenic and prevalence of diabetes mellitus. Am J Epidemiol (1994) 2.17
Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. J Natl Cancer Inst (2001) 2.11
Arsenic methylation capacity and skin cancer. Cancer Epidemiol Biomarkers Prev (2000) 2.07
An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene. Cell (1988) 2.01
Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseniasis-hyperendemic villages in Taiwan. Environ Health Perspect (2000) 1.98
Rat gene encoding the 78-kDa glucose-regulated protein GRP78: its regulatory sequences and the effect of protein glycosylation on its expression. Proc Natl Acad Sci U S A (1987) 1.87
Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer. Cancer Epidemiol Biomarkers Prev (1997) 1.84
Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol (1997) 1.83
Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke (1997) 1.81
Sudden infant death syndrome in relation to weather and optimetrically measured air pollution in Taiwan. Pediatrics (1995) 1.79
Epidemiologic study of the prevalence and severity of myopia among schoolchildren in Taiwan in 2000. J Formos Med Assoc (2001) 1.79
Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes. J Clin Microbiol (1999) 1.77
Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol (1998) 1.72
Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int J Cancer (1996) 1.71
Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutat Res (1997) 1.69
Hepatitis B virus markers in Chinese twins. Anticancer Res (1989) 1.68
The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study. Cancer (1992) 1.68
Human papillomavirus and cervical neoplasia: a case-control study in Taiwan. Int J Cancer (1995) 1.66
Multiple risk factors associated with arsenic-induced skin cancer: effects of chronic liver disease and malnutritional status. Br J Cancer (1995) 1.65
Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med (1997) 1.63
Cryptococcal meningitis in non-HIV-infected patients. QJM (2000) 1.63
Bacteremia caused by Arcobacter cryaerophilus 1B. J Clin Microbiol (1997) 1.59
Characterization of the hgbA locus encoding a hemoglobin receptor from Haemophilus ducreyi. Infect Immun (1995) 1.56
Mortality attributable to cigarette smoking in Taiwan: a 12-year follow-up study. Tob Control (1998) 1.47
Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides. Biochemistry (1997) 1.46
Association between cytomegalovirus-specific reactivity of T cell subsets and development of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. J Infect Dis (2001) 1.46
Seasonal pattern of posttraumatic stress disorder admissions. Compr Psychiatry (1996) 1.44
Elevated levels of anticardiolipin antibodies and epilepsy in lupus patients. Lupus (1996) 1.44
CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst (1997) 1.43
A calcium ionophore-inducible cellular promoter is highly active and has enhancerlike properties. Mol Cell Biol (1986) 1.40
Klebsiella pneumoniae meningitis: timing of antimicrobial therapy and prognosis. QJM (2000) 1.40
Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993. Infect Control Hosp Epidemiol (1997) 1.38
Impaired pulmonary function as a risk factor for mortality. Am J Epidemiol (1982) 1.38
Extralobar pulmonary sequestration presenting as an anterior mediastinal tumor in an adult. Chest (1993) 1.38
Induction of apoptosis in murine coronavirus-infected cultured cells and demonstration of E protein as an apoptosis inducer. J Virol (1999) 1.38
Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun (1993) 1.38
A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers. Hepatology (1999) 1.38
Usefulness of AgNOR score in differentiating benign from malignant pulmonary aspiration cytology. Acta Cytol (1997) 1.38
Nation-wide survey of myopia among schoolchildren in Taiwan, 1986. Acta Ophthalmol Suppl (1988) 1.38
Cooking oil absorption by foods during Chinese stir-frying: implications for estimating dietary fat intake. J Am Diet Assoc (1993) 1.37
Neurilemmoma of the vagus nerve. A case report and brief literature review. Laryngoscope (1984) 1.37
A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer (1988) 1.35
Low serum carotene level and increased risk of ischemic heart disease related to long-term arsenic exposure. Atherosclerosis (1998) 1.35
Occupational exposure to wood, formaldehyde, and solvents and risk of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev (2001) 1.34
Emergence of vancomycin-resistant enterococci at a university hospital in Taiwan: persistence of multiple species and multiple clones. Infect Control Hosp Epidemiol (1999) 1.34
Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. JAMA (2000) 1.33
Crystal structure of the transcription factor sc-mtTFB offers insights into mitochondrial transcription. Protein Sci (2001) 1.33
Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood (1991) 1.32
Comparative impact of hospital-acquired infections on medical costs, length of hospital stay and outcome between community hospitals and medical centres. J Hosp Infect (2005) 1.32
Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan. J Toxicol Environ Health A (1998) 1.32
Cigarette smoking, alcohol consumption and risk of nasopharyngeal carcinoma in Taiwan. Cancer Causes Control (1999) 1.32
Elevated serum testosterone levels and risk of hepatocellular carcinoma. Cancer Res (1993) 1.31
A role for inositol 1,4,5-trisphosphate in gravitropic signaling and the retention of cold-perceived gravistimulation of oat shoot pulvini. Plant Physiol (2001) 1.29
Structure of the Ca2+-regulated photoprotein obelin at 1.7 A resolution determined directly from its sulfur substructure. Protein Sci (2000) 1.29
Specific interaction between the hepatitis C virus NS5B RNA polymerase and the 3' end of the viral RNA. J Virol (1999) 1.28
Cloning of a gene (PSD1) encoding phosphatidylserine decarboxylase from Saccharomyces cerevisiae by complementation of an Escherichia coli mutant. J Biol Chem (1993) 1.28
An evaluation of maximum likelihood reconstruction for SPECT. IEEE Trans Med Imaging (1990) 1.28
Invasive amoebiasis: an emerging parasitic disease in patients infected with HIV in an area endemic for amoebic infection. AIDS (1999) 1.27
Excess injury mortality among smokers: a neglected tobacco hazard. Tob Control (2005) 1.25
CD34, CD117, and actin expression in phyllodes tumor of the breast. J Surg Res (2000) 1.24
Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Atherosclerosis (1996) 1.24
Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD. Eur Respir J (2004) 1.23
Signal transduction in the carnivorous plant Sarracenia purpurea. Regulation of secretory hydrolase expression during development and in response to resources. Plant Physiol (1997) 1.23
Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer. Cancer Epidemiol Biomarkers Prev (1997) 1.23
p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res (1997) 1.23
Antioxidative activity of polysaccharide fractions isolated from Lycium barbarum Linnaeus. Int J Biol Macromol (2009) 1.23
Persistent hyperendemicity of hepatitis C virus infection in Taiwan: the important role of iatrogenic risk factors. J Med Virol (2001) 1.22
Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst (2000) 1.22
The amino-terminal C/H1 domain of CREB binding protein mediates zta transcriptional activation of latent Epstein-Barr virus. Mol Cell Biol (1999) 1.22
Tobacco, betel quid, alcohol, and illicit drug use among 13- to 35-year-olds in I-Lan, rural Taiwan: prevalence and risk factors. Am J Public Health (2001) 1.22
Inducible and conditional inhibition of human immunodeficiency virus proviral expression by vesicular stomatitis virus matrix protein. J Virol (1995) 1.21
A novel spliced transcript of influenza A/WSN/33 virus. Virus Genes (1998) 1.21
Healthcare-associated outbreak due to pan-drug resistant Acinetobacter baumannii in a surgical intensive care unit. J Hosp Infect (2003) 1.21
PTEN/MMAC1 mutations in hepatocellular carcinomas. Oncogene (1999) 1.20
Genetic polymorphisms of XRCC1 and risk of the esophageal cancer. Int J Cancer (2001) 1.20
Risk of betel chewing for oesophageal cancer in Taiwan. Br J Cancer (2001) 1.20
Clinical features and in vitro susceptibilities of two varieties of Cryptococcus neoformans in Taiwan. Diagn Microbiol Infect Dis (2000) 1.19
Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. J Med Virol (1999) 1.18
Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res (1991) 1.18